JSM 2011 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Activity Details
|
|||
112 * | Mon, 8/1/2011, 8:30 AM - 10:20 AM | CC-D236 | |
Progress in the Use of Genomic Biomarkers in Clinical Trials — Topic Contributed Papers | |||
Biometrics Section , ENAR , International Chinese Statistical Association , Committee of Representatives to AAAS | |||
Organizer(s): Peggy H. Wong, Merck & Co., Inc. | |||
Chair(s): Sue-Jane Wang, U.S. Food and Drug Administration/CDER | |||
8:35 AM | The Role of the Cutoffs in Developing the Genomic Classifier for Clinical Utility Assessment — Samir Lababidi, U.S. Food and Drug Administration ; Sue-Jane Wang, U.S. Food and Drug Administration/CDER | ||
8:55 AM | Statistical Challenges in Genetic Biomarker Treatment Association with Clinical Outcomes: Experience from an Infectious Disease Phase II and Phase III Trials — Peggy H. Wong, Merck & Co., Inc. ; Navdeep Boparai, Merck & Co., Inc. | ||
9:15 AM | Challenges in Developing and Validating Biomarkers That Are Treatment Induced: Experiences from an Oncology Phase III Trial — Bin Yao, Amgen Inc. ; Yining Ye, Amgen Inc. | ||
9:35 AM | Identifying Predictive Biomarkers in Oncology Trials: A Practical Example from a Randomized Phase II Study in Neo-Adjuvant Breast Cancer (BC) — Pralay Mukhopadhyay, Bristol-Myers Squibb ; Guan Xing, Bristol-Myers Squibb ; Li-An Xu, Bristol-Myers Squibb ; David Liu, Bristol-Myers Squibb ; Christine Horak, Bristol-Myers Squibb | ||
9:55 AM | Robust and Reproducible Analysis of a Very Large Clinical Genomics Study — John Storey, Princeton University | ||
10:15 AM | Floor Discussion |
2011 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.